Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: -others

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Laetitia Fend, et al. Cancer Research, July 2017, DOI: 10.1158/0008-5472.CAN-16-2165 – Download the article Publication

Published 24 July 2017
Categorized as -others, 2017, Publication, TG6002

TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma

Ahmed Idbaih, et al. ASCO 2017, June 2017 – Download the abstract Abstract

Published 5 June 2017
Categorized as -others, 2017, Publication, TG6002

Local and Abscopal Effects in Oncolytic Virotherapy are boosted by Immune Checkpoint Blockade, Immunogenic Chemotherapy, or IFNAR blockade

Laetitia Fend, et al.AACR, American Association for cancer Research, April 2017Download the poster herePoster Presentation

Published 5 April 2017
Categorized as -others, 2017, Publication, TG1050

In situ Biomarker analysis in cancer Immunotherapy: development of quantitative multiplex IHC

Sandrine Cochin, et al. CLARA, Forum de la recherche en cancérologie, April 2017 Download the poster here Poster Presentation

Published 2 April 2017
Categorized as -others, 2017, Publication Tagged Oncolytic virus, Poster presentation

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen

Gilda G. Hillman, et al. Journal for ImmunoTherapy of Cancer, January 2017 – Download the article Publication

Published 20 January 2017
Categorized as -others, 2017, Publication Tagged Poster presentation, Therapeutic Vaccine

TG1050, an HBV-targeted immunotherapeutics, efficiently decreases HBV viremia and antigenemia in a preclinical model; a meta-analysis and the determination of the involvement of CD4 and CD8 T cells.

Roland Kratzer, et al. AASLD & Hepatology, October 2016 – DOI: 10.1002/hep.28800 Download the poster here Poster Presentation

Published 14 November 2016
Categorized as -others, 2017, Publication, TG1050 Tagged Poster presentation, Therapeutic Vaccine

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allow their intratumoral delivery and an improved tumor growth inhibition

Patricia Kleinpeter, et al.OncoImmunology, October 2016 – Download the articlePublication

Published 28 October 2016
Categorized as -others, 2017, Invir.IO, Publication

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allow their intratumoral delivery and an improved tumor growth inhibition

Patricia Kleinpeter, et al.OncoImmunology, October 2016 – Download the articlePublication

Published 18 October 2016
Categorized as -others, 2016, Invir.IO, Publication

Engineering Oncolytic Vaccinia Virus with Improved Cancer Killing Abilities

Johann Foloppe, et al.10th International Meeting on Replicating Oncolytic Virus Therapeutics, Vancouver, Canada – 1-4 October 2016Download the poster herePoster Presentation Collaboration between Transgene – HTS facility IGBMC, Illkirch – France IREBS, Illkirch, France – ICube, Strasbourg, France

Published 5 October 2016
Categorized as -others, 2017, Publication

Evaluation of a novel oncolytic Raccoonpox virus expressing the bifunctional FCU1 suicide gene

Marine Ricordel, et al. XXI International Poxvirus, Asfavirus and Iridovirus Conference Le Bischenberg (France) 1-5 July 2016 Download the poster here Poster Presentation

Published 1 July 2016
Categorized as -others, 2016, Publication

Posts pagination

Newer posts Page 1 … Page 7 … Page 10 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu